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Introduction
It is widely accepted that individual behaviour pat-
terns, particularly diet and exercise, affect health sta-
tus through impact on multiple systems. These
relationships have been convincingly demonstrated
in various disease states, including cardiovascular dis-
ease (e.g. myocardial infarction, stroke) and meta-
bolic conditions (e.g. diabetes) (1,2). However, less
recognised is the relationship between behaviour and
bladder health.
Similar to other disease states, some behavioural
and lifestyle factors can precipitate or exacerbate
bladder conditions, and as such represent bladder
health risks, whereas other factors can contribute
positively to bladder health by preventing or modify-
ing existing bladder conditions (3,4). Currently,
some of the evidence supporting which specific fac-
tors represent a bladder health risk or whether they
are modifiable is limited. However, awareness and
implementation at a societal level of behavioural
modifications that are established to prevent or
reverse bladder disease/dysfunction may lead to a
substantial reduction in the human and economic
burdens of impaired bladder health, as well as an
improvement in overall health.
In this article, we review the current state of
knowledge on behavioural and lifestyle factors
that influence bladder conditions,
including the lower urinary tract
symptoms (LUTS) of urinary incon-
tinence (UI), urgency, frequency and
nocturia, as well as urinary tract
infection (UTI), bladder pain syn-
drome/interstitial cystitis (BPS/IC)
and bladder cancer. Among the
behavioural factors considered are
cigarette smoking, dietary intake,
body-mass index, fluid intake, void-
ing habits and techniques, bowel
habits, physical activity and exercise,
and pelvic floor muscle skills and
exercise. In addition, we describe
potential modifications of these
behavioural and lifestyle factors that
could reduce or ameliorate risk and
optimise bladder health and also
provide suggestions to incorporate
behavioural modifications into pub-
lic health programmes. Our goals
are to increase awareness of the relationship between
behaviour and bladder health, to stimulate changes
in both public decision-making and individual hab-
its, and to promote incorporation of behavioural
modifications discussed here into public health pro-
grammes in an effort to improve both bladder health
and overall health at a population-based level.
Behavioural and lifestyle factors that
influence bladder health
Cigarette smoking
Cigarette smoking is directly correlated with the
development of bladder cancer. Smokers have a
threefold higher risk of bladder cancer, and the
American Cancer Society reports that the incidence
increases with advancing age (5). The duration of
smoking appears to be particularly relevant (6,7). In
a population-based study of smoking practices and
risk of bladder cancer, smoking fewer cigarettes over
a long period of time was found to be more harmful
than smoking more cigarettes over a shorter period
of time (7). Gender may also be associated with
bladder cancer incidence, as it has been demon-
strated that the risk of bladder cancer among smok-
ers is significantly higher in women compared with
men who smoked a comparable amount of cigarettes
over the same length of time (8). The exact causal
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pathway between smoking and bladder cancer risk
has not yet been established; however, various chemi-
cals in cigarettes, such as nicotine, have known car-
cinogenic properties, and smoking is associated with
abnormal growth of bladder lining cells (9).
Smoking cessation has been shown to decrease the
risk of bladder cancer (8,10). Thus, there is an ongo-
ing need for educational initiatives to convey infor-
mation explaining the need to quit smoking, as well
as smoking cessation programmes to assist individu-
als, including those with or at increased risk for
developing bladder cancer, to change their behaviour
(11,12). Health professionals have a critical role in
disseminating information to populations they inter-
act with regarding the risk of bladder cancer associ-
ated with smoking and in encouraging smoking
cessation (12).
In addition to its link to bladder cancer, smoking
has also been associated with increased risk of BPS/
IC and other LUTS, including UI, frequency,
urgency, nocturia, incomplete emptying and hesi-
tancy (13–25). In a cross-sectional study of women
seeking gynaecological care, an association was found
between bladder pain and current smoking; tobacco
use was the only modifiable risk factor identified
(22). In a case–control study of women with and
without UI, it was demonstrated that previous and
current cigarette smoking increased the odds of both
stress UI and urgency UI (13). When modifiable life-
style factors associated with UI were examined in a
large, epidemiological study, heavy smoking (former
or current) had one of the highest odds ratios (14).
A prospective cohort study comparing smokers
and non-smokers determined that smokers had a
stronger urethral sphincter, which may have a pro-
tective effect against stress UI. However, the authors
concluded that violent coughing by smokers was
likely to contribute to stress UI because of earlier
development of anatomical and pressure transmis-
sion defects, leading to weakening of the sphincters
(15). Whether the coughing is causally related to
stress UI, exacerbates the condition, or contributes to
earlier development has not yet been elucidated.
In a longitudinal study, smoking increased the 1-
year incidence of overactive bladder in women, but
did not significantly affect the risk of stress UI (25).
In men, smoking has been associated with both over-
active bladder and prostatic enlargement
(17,18,23,24), although results have been inconsistent
(20,26). In a longitudinal study of men aged 40–
70 years, cigarette smoking was associated with inci-
dent benign prostatic enlargement (23) and it was
suggested that avoidance of smoking might be of
benefit. A population-based cross-sectional study of
men in Austria also showed a positive correlation
between the International Prostate Symptom Score
(used to assess benign prostatic enlargement symp-
tomatology) and the daily nicotine usage of current
smokers (24). In this study, the association with nic-
otine was shown for storage symptoms, but not for
voiding symptoms associated with benign prostatic
enlargement.
Dietary intake
Although nutrition-based interventions or activities
have historically been focused on disease states such
as cardiovascular and metabolic conditions, ample
evidence suggests that it may be beneficial to incorpo-
rate the impact of dietary intake on bladder health.
Caffeine
Foods and beverages containing caffeine have been
reported to be risk factors for urgency, frequency
and UI. Caffeine promotes urgency and frequency
through diuresis, decreased threshold of sensation at
filling phase, and increased flow rate and voided vol-
ume (27,28). The association of daily caffeine intake
with UI is described in a prospective cohort study of
65,176 adult women (27). A significant association
with weekly incontinence was reported for the group
with the highest (> 450 mg/day) vs. the lowest
(< 150 mg/day) caffeine intake (RR 1.19, 95% CI
1.06–1.34). Risk of UI associated with high caffeine
intake was 25% (27).
Alcohol
Alcohol can promote urgency and frequency by
interfering with the bladder signals regulating mictu-
rition. Alcohol also acts as a diuretic and causes
dehydration (29). A study in men concluded that
among other factors, alcohol consumption was an
avoidable risk factor for the development of LUTS
(30). Another study in men aged  20 years dem-
onstrated that high alcohol consumption was a factor
positively associated with an increased risk of moder-
ate and severe LUTS (31). However, studies are
inconsistent, with some showing an inverse relation-
ship between alcohol consumption and the incidence
of overactive bladder (26) and benign prostatic
enlargement (23,32,33). A meta-analysis of 19 studies
(120,091 men) demonstrated that alcohol reduced
the risk of benign prostatic enlargement, but not
LUTS (32). The causal pathways and exact mecha-
nisms that are associated with this reduction in risk
are still in an exploratory phase (32).
Bladder irritants
In addition to caffeine and alcohol, several foods and
beverages have been identified as triggering or exacer-
bating urinary symptoms, particularly in patients with
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Table 1 Bladder- and prostate-friendly foods
Food type Eat Try it Avoid
Beverages Chamomile tea, Evian, pear juice,
pure blueberry juice,
milk, peppermint tea, almond milk,
rice milk, Lactaid,
non-dairy creamer, non-alcoholic eggnog
Alfalfa tea, bottled water, herbal coffees,
low-acid decaf coffee, roasted carob
tea or coffee, low-acid juices, gin, rice milk,
decaf root beer w/ice (not diet), rum, tap water,
vodka, some sports drinks
Alcohol, carbonated water,
flavoured water, chocolate milk,
citrus juices, cranberry juice,
herb tea blends, green teas,
most fruit juices, regular coffee,
sodas, soy milk, tea,
energy drinks, powdered drinks
Grain products Buckwheat, cornbread, white bread,
oat bread, pita, potato bread,
couscous, matzo, millet, oatmeal,
pasta, rice, quinoa, rice,
spelt, most cereals
Amaranth, grits, rye bread, sourdough bread,
some graham crackers without problem ingredients,
whole wheat bread, instant hot cereals
Breads or cereals with preservatives,
soy flour, prepared pasta or
rice dishes
Fats and nuts Peanuts, butter, canola oil,
coconut w/o preservatives,
coconut oil, corn oil, margarine,
olive oil, peanut oil,
safflower oil, sesame oil,
shortening, soy oil,
homemade salad dressings
Almonds, almond butter, cashews, tahini,
sunflower seeds, butter-flavoured shortening
Filberts, hazelnuts, macadamia nuts,
mayonnaise, most prepared salad
dressings, peanuts, pecans,
pistachio nuts, English and black
walnuts
Soups Homemade soups with
non-problem meats
(see below) and vegetables
Canned, low sodium, organic soups without
problem ingredients
Bouillon cubes, bouillon powder,
most packaged and canned soups
Meat, fish
and poultry
Beef, chicken, eggs, fish, lamb, liver
(beef or chicken), pork,
shellfish, fresh crabmeat, shrimp,
turkey, veal, whey protein powder
Anchovies, bacon, Canadian bacon, caviar,
corned beef, liverwurst, prosciutto, some
sausages without problem ingredients,
ham, soy-free veggie burgers
Bologna, hot dogs, most sausage,
pepperoni, salami, smoked fish,
canned crabmeat, soy products
Cheeses and
other dairy
Cream cheese, cottage cheese,
feta, mozzarella, ricotta,
string cheeses, American
cheese, whipped cream,
ice cream, milk, Lactaid, rice milk
Buttermilk, canned parmesan cheese, Monterey jack,
Cool Whip, some sherbets,
some frozen yogurt, Rice Dream
Aged cheeses, blue cheese, brie,
brick parmesan, camembert,
cheddar, edam, emmentaler,
gruyere, hard jack, roquefort,
sorbet, soy milk, soy cheese,
Sour cream, stilton, swiss,
Cheez Wiz, yogurt
Vegetables and
dried beans
Broccoli, brussels sprouts, cabbage, carrots,
cauliflower, chives, collard greens,
corn, cucumber, kale, lentils, lettuce,
mustard greens, mushrooms,
most dried beans, okra, parsley, peas,
potatoes, pumpkin, radishes, snow peas,
split peas, summer squash,
turnips, winter squash, yams, zucchini
Avocado, beets, chicory, cooked bulb, onions,
cooked leeks, dandelion greens, eggplant,
low-acid tomatoes, purslane, raw green onions,
rhubarb, rutabagas, swiss chard, spinach,
turnip greens, watercress
Chilli peppers, black beans, fava beans,
lima beans, pickles, raw bulb onions,
sauerkraut, soy beans, (edamame),
tomato, tomato sauces,
tomato juice, tofu
Fruits Dates without preservatives, coconut
without preservatives, pears,
apples, homemade applesauce,
watermelon
Bananas, brown raisins, cherimoya, citrus peels,
crenshaw melon, dried currants, Gala apples,
honeydew, mango, maraschino cherries, rhubarb
Apricots, all citrus fruit, cantaloupe,
cherries, dried fruit peaches,
most plums, most dried figs,
golden raisins, grapes, guava,
kiwi fruit, most berries,
passion fruit, papaya, persimmon,
pineapple, starfruit
Snacks Almonds, carrots, celery, plain corn chips,
plain potato chips, soda crackers,
oatmeal bars, peanuts, popcorn, pretzels
Glazed doughnuts, graham crackers, fruit and
nut bars with OK ingredients, licorice,
pizza with OK ingredients
Seasoned potato chips, processed
baked goods, dessert
cakes – fast food restaurants
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the symptoms of BPS/IC (urinary urgency and/or
frequency, pressure and pain; Table 1) (34–36). A
study in women aged  40 years demonstrated
that carbonated beverages increased the 1-year inci-
dence of overactive bladder and stress UI (25). There
are a number of ingredients that might account
for this effect (37). For example, diet sodas contain
four well-known bladder irritants: acidic carbonation,
citric and other acids, caffeine and artificial sweet-
eners (29).
Certain foods may stimulate and sensitise nerves
in the bladder, which can exacerbate the already
heightened nerve sensitivity present in individuals
with BPS/IC. Other foods are high in histamine, an
irritating substance that can provoke mast cells,
which are increased and activated in certain patients
with BPS/IC (29,38). A study investigating the possi-
ble association between dietary factors and the onset
of stress UI in women aged  40 years demon-
strated that total fat, saturated fatty acids and mono-
unsaturated fatty acids were associated with an
increased risk of stress UI (39). Another study
reported that a diet low in fat and red meat and high
in protein and vegetables may reduce risk of symp-
tomatic benign prostatic enlargement (33).
Guidance is available for the elimination or modi-
fication in foods, beverages, food ingredients and
nutrients that have been identified as risk factors for
bladder conditions, but there may be considerable
variability between individuals (34). A Painful Blad-
der Syndrome/Interstitial Cystitis Ad Hoc Committee
on Diet published a list of ‘bladder- and prostate-
friendly foods’ with the intention of helping patients
modify their diets to improve bladder health. Eating
and drinking ‘bladder-friendly’ foods and beverages
and/or limiting the consumption of foods or bever-
ages known to irritate the bladder to moderate levels
can help prevent bladder irritation (37).
Cancer risk factors
Certain foods/nutrients and beverages, including
alcohol, may increase the risk of bladder cancer,
whereas other foods may decrease the risk (40–43).
A population-based study investigating the effect of
dietary micronutrients on the risk of bladder cancer
demonstrated that calcium intake was associated with
higher risk (41). Additional analysis of this popula-
tion revealed a possible association between bladder
cancer and a high intake of cheese, while noting a
protective effect for olive oil (42).
Vitamin D
There is now a body of literature supporting the pro-
tective role of vitamin D in maintaining continence
Table 1 Continued
Food type Eat Try it Avoid
Desserts
and sweets
Brown sugar, carob, carrot muffins or cake,
creme brulee, custards, divinity,
homemade pound cake,
homemade white/yellow cakes,
homemade vanilla frosting, homemade
caramel frosting, honey,
licorice, maple syrup, pear pastries,
sugar, sugar cookies, tapioca,
vanilla ice cream, vanilla pudding
Banana bread, blueberry pastries, caramel candies,
peppermint ice cream, plain pastries with almonds,
plain cheesecakes, some frozen yogurt, some hard
candies without acids, some popsicles,
Splenda (sucralose), stevia, white chocolate
Acesulfame K, aspartame, catsup,
milk chocolate, dark chocolate,
coffee ice cream, desserts with
problem nuts, mustard, pastries
with problem fruits, pecan pie,
sorbets, store-bought fruitcakes,
mincemeat pie, Nutrasweet,
saccharine
Seasonings
and additives
Allspice, almond extract, anise, basil,
caraway seed, coriander, dill, fennel, garlic,
mace, marjoram, oregano, poppy seed,
rosemary, sage, salt, thyme,
tarragon, vanilla extract
Black pepper, celery seed, cilantro, cinnamon, cumin
(small amount), dried parsley, dried chervil, ginger,
lemon extract, malt powder, nutmeg, onion powder,
orange extract, turmeric
Ascorbic acid, autolyzed yeast,
butylated hydroxyanisole (BHA)
and butylated hydroxytoluene (BHT),
benzoates, caffeine, cayenne, cloves,
chilli powder, citric acid, hot curry
powder, hydrolyzed protein, meat
tenderizers, miso, oleoresin paprika,
paprika, red pepper, soy sauce,
tamari, vinegar, Worcestershire
sauce, MSG (monosodium,
glutamate), metabisulphites, sulphites
Fibre supplements Acacia fibre, Benefiber, plain Metamucil Colace, Metamucil cinnamon wafers Metamucil orange, Metamucil berry
burst, sugar-free psyllium fibre, senna
Adapted from IC/PBS Ad Hoc Committee on Diet. 2009 IC/PBS Food List: Bladder & Prostate Friendly Foods; and Understanding Diet and IC. Available at: http://
www.ic-network.com/handbook/diet.html. Accessed 12 January 2012.
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in women and men. Three large epidemiologic stud-
ies have provided evidence linking UI risk with
insufficient vitamin D levels (44–46). One study
investigated the association between nutrient compo-
sition of the diet and the onset of overactive bladder
and UI in community-dwelling women  40 years
of age (44). After a year, higher vitamin D intake
was significantly associated with a decreased risk of
the onset of overactive bladder and UI in women.
Another study characterised the prevalence of vita-
min D deficiency in non-pregnant women with
pelvic floor disorders in the National Health and
Nutrition Examination Survey (NHANES) (45).
Multivariable analysis revealed that the likelihood of
UI was significantly reduced by 45% when vitamin D
levels were normal. In the third study, NHANES data
showed that men with deficient vitamin D levels had
a significantly higher rate of moderate/severe UI and
a greater likelihood of having  1 LUTS, including
nocturia, incomplete emptying, hesitancy and UI
(46). Because vitamin D receptors exist in many tis-
sues and organ systems, it is possible that vitamin D
may help prevent UI and other bladder symptoms by
increasing pelvic floor muscle strength, improving
urethral sphincter function, inhibiting detrusor
muscle overactivity and/or decreasing prostatic
hypertrophy.
Cranberry products
Diet can also play a role in the development of UTIs,
particularly in women for whom UTIs are the most
common infection. Cranberries, cranberry juice and
cranberry supplements have been shown to have a
protective or preventative effect against UTI, particu-
larly recurrent UTIs in women (47,48). A-type pro-
anthocyanidins, which are a component of
cranberries, inhibit bacterial adherence to the uroepi-
thelium in a dose-dependent manner (49,50).
Despite this, there is conflicting evidence and not all
studies have been supportive.
In a study comparing the antibiotic trimethoprim-
sulfamethoxazole (TMP-SMX) with cranberry sup-
plements in 221 premenopausal women with recur-
rent UTIs, participants in the TMP-SMX group had
fewer symptomatic UTIs over 12 months than those
in the cranberry supplement group; however, antibi-
otic resistance increased in the TMP-SMX group and
not in the cranberry group (51). Another study eval-
uated the effect of drinking 8 ounces of cranberry
juice twice daily on the risk of recurring UTI among
319 college women with an acute UTI; those drink-
ing cranberry juice did not have a decreased
6-month incidence of a second UTI compared with
placebo (52). Even with conflicting evidence, incor-
porating the recommendation of cranberry intake as
a protective measure in community-based interven-
tions, such as sexual health interventions or healthy
ageing interventions, may help reduce the risk for
UTIs among highly susceptible populations.
Drug abuse
Severe LUTS, including urgency, UI, frequency and
nocturia, as well as cystitis, haematuria, reduced
bladder capacity, hydronephrosis and renal impair-
ment have been associated with ketamine abuse (53).
The mechanism(s) producing these effects on the
bladder is unknown. Symptoms appear to improve
after cessation of ketamine in cases where irreversible
damage to the renal tract has not occurred (53).
Body-mass index
Related to dietary intake is the ability to maintain a
healthy weight. Obesity is an established risk factor
for UI, as demonstrated in several population-based
studies (14,54). In addition, several weight loss inter-
vention studies have demonstrated that weight loss is
associated with reductions in UI (55–57). The most
definitive randomised clinical trial showed that over-
weight and obese women who participated in a 6-
month behavioural weight loss intervention (resulting
in an 8% weight loss) reduced UI episodes by 47%
(compared with 28% in the control group) and
reduced urgency UI episodes by 42% (compared with
26% in control) (57). Elevated body-mass index also
appears to be associated with increased incidence of
nocturia and increased risk for UTI (58–60). In men,
obesity is associated with benign prostatic enlarge-
ment and increased risk of LUTS (61,62). Given the
benefits of weight loss for urinary symptoms, it might
be prudent to integrate this information into weight
loss programmes to provide an added incentive for
overweight men and women to engage in the long-
term behaviour changes needed to lose weight.
Fluid intake volume
Fluid intake volume is also an important factor
affecting bladder function, as consuming a healthy
amount of fluid can help prevent UI and other blad-
der conditions (16,63–66). Limiting fluid intake is
sometimes used as a self-directed ‘preventative’ strat-
egy by those experiencing urgency, frequency, noctu-
ria or UI (3,63,64,67). However, this practice can
increase urine concentration, leading to irritation of
the bladder mucosa, thereby increasing the incidence
of LUTS and UTI (68,69).
Conversely, excessive fluid intake may exacerbate
urinary symptoms. Fluid intake averaging
> 3700 ml/day has been associated with a higher
voiding frequency and incidence of UI compared
with an intake of approximately 2400 ml/day (70). A
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study of 30 healthy men aged 21–32 years demon-
strated that participants in the excessive fluid intake
group not only had significantly increased urine vol-
ume and frequency but also had significantly higher
bladder pressure compared with those in the normal
fluid intake group (71). Excessive evening fluid
intake in particular may predispose individuals to
nocturia, especially older adults and other individuals
who experience nocturnal polyuria as a result of
sleep apnoea, heart failure or other medical condi-
tions affecting urine production (16,66).
Overall, promoting healthy fluid intake (approxi-
mately 25–30 ml/kg/day) may dilute the urine, bal-
ance the pH of urine, reduce bladder irritation and
help prevent UTIs (16,63,65,66). In addition, healthy
fluid intake (especially water) may reduce risk of
bladder cancer (65,72).
Voiding habits and technique
Voiding frequency
Voiding frequency can be driven by many factors,
including bladder sensation, convenience, opportu-
nity, health beliefs and fear of UI episodes. Excessive
frequency of voiding is often adopted as a strategy to
avoid urgency and UI episodes (73). However, it is
thought that frequent voiding, over time, leads to
reduced functional bladder capacity and bladder dys-
function (74). Conversely, infrequent voiding may
irritate the bladder mucosa, increasing the incidence
of LUTS and UTI (68,69). It is also possible that
infrequent voiding may overdistend the bladder,
leading to reduced the awareness of bladder sensa-
tion, and contribute to UTI (75).
Postcoital voiding
Sexual intercourse has been positively correlated with
UTIs. Proper hygiene, particularly postcoital hygiene
for women, including emptying the bladder following
sexual intercourse, has been recommended for the
prevention of UTIs (76). Public health sexual educa-
tion programmes should incorporate these concepts
to inform individuals of the importance of bladder
health to highlight that the occurrence of UTI in this
context can be circumvented.
Voiding technique
Without an understanding of normal bladder func-
tion, people may develop the habit of voiding by val-
salva (bearing down) or fail to relax the pelvic floor.
Some women in particular report hovering over pub-
lic toilet seats to avoid contact with unclean surfaces,
which makes it difficult to relax and empty the blad-
der (77,78). Improper voiding techniques can lead to
dysfunctional voiding and incomplete emptying,
which may increase voiding frequency and risk of
UTI (79).
Healthy toileting behaviours include a relaxed
position for urination, relaxation of the pelvic floor
and allowing adequate time for the bladder to empty
(77,78,80–84). Public education, including messages
for children and young adults, to disseminate a clear
understanding of how the bladder fills and empties,
normal voiding habits and problems associated with
poor habits has potential to promote bladder health
on a population level.
Bowel habits and constipation
Bowel health is known to affect bladder function, espe-
cially in older adults. Specifically, faecal impaction and
constipation are associated with LUTS, including OAB
symptoms of urgency, urgency UI, frequency and
nocturia, as well as incomplete emptying (85,86). Fur-
thermore, treatment of constipation has been shown
to improve LUTS in children and adults (87–89).
Physical activity and exercise
The duration and level of competition have been
correlated with LUTS across several sports, with high
impact sports more frequently associated with UI
than low impact sports (90). High impact sports
appear to be associated with functional and anatomi-
cal changes in pelvic floor muscles. For female ath-
letes who endure high impact, frequent intense
training in landing/jumping sports (e.g. gymnastics,
basketball), increased size and altered function of
pelvic floor muscles have been demonstrated com-
pared with athletes who participated in non-landing/
jumping sports (e.g. swimming, walking) (91).
On the other hand, long-term, moderate physical
activity has been shown to be inversely related to UI
(92), and lower activity levels have been associated
with 2–3 times greater likelihood of incident LUTS
in women (20). Furthermore, most studies in men
indicate that physical activity decreases the risk of
benign prostatic enlargement, suggesting that physi-
cal activity may be beneficial in men with LUTS
(61). Thus, public health programmes addressing
inactivity levels or promoting exercise programmes
could incorporate the potential benefit of physical
activity to bladder health as an added incentive.
Pelvic floor muscle skills and exercise
Healthy pelvic floor muscle function is an important
factor for the maintenance of overall bladder health.
Keeping muscles strong maintains tone, supports pel-
vic organs and promotes active use of pelvic floor
muscles to control the bladder outlet.
Pelvic floor muscle training is a well-established
treatment for stress UI in women, as well as men
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(93,94). Behavioural training, which combines pelvic
floor muscle training with urge suppression strategies,
has proven effective for reducing urgency, frequency,
nocturia and urgency UI in women and in men (3,74).
Given the efficacy of these behavioural approaches to
treating bladder symptoms, their low side effect profile
and safety, they have also been examined as preventive
interventions in high-risk populations, including
child-bearing women, older women and men under-
going radical prostatectomy (95,96).
A systematic review comparing antenatal and post-
natal care including pelvic floor muscle training with
standard care demonstrated that pelvic floor muscle
training may prevent UI in late pregnancy and post-
partum and may effectively reduce persistent UI
thereafter (97). Thus, public health initiatives aimed
at improving the overall health of pregnant women
should include education on executing pelvic floor
muscle exercises to prevent or reverse compromised
pelvic floor muscle function.
Although age is an established risk factor for UI,
there is a single randomised clinical trial demonstrat-
ing the value of pelvic floor muscle training in a
behaviour modification programme for reducing 12-
month incidence of UI and 24-h, daytime and noctur-
nal voiding frequency in continent older women (98).
Because UI is often predictable after radical pro-
statectomy, behavioural interventions have also been
implemented in the early postoperative period to
help reduce symptom duration and severity (99,100).
Another approach is to teach pelvic floor muscle
control preoperatively, so that patients can practise
their muscle skills before surgery and be more pre-
pared to exercise and use their pelvic floor muscles
immediately after catheter removal (96). There are
now several randomised controlled clinical trials of
peri-operative pelvic floor muscle training pro-
grammes that have shown reduced duration and
severity of UI after prostatectomy (96,99,100).
Given the preventive value of safe behavioural
intervention within at-risk populations, and our rela-
tive inability to predict who will develop bladder
conditions, it is reasonable to consider the potential
value of these interventions for preventing bladder
symptoms on a broader population scale. Educating
women and men about pelvic floor muscle exercises
may enable them to consciously maintain better
muscle tone and support for pelvic organs including
the bladder and urethra. Pelvic floor muscle exercise,
which has been used to prevent UI during pregnancy
and following delivery, may be employed to prevent
or deter pelvic floor weakening associated with age-
ing or weight gain. Better pelvic floor muscle relaxa-
tion may help people to void more naturally and
effectively, and prevent problems with dysfunctional
voiding. Educating individuals about how to contract
their pelvic floor muscles to brace during coughing,
sneezing and heavy lifting may help preserve the pel-
vic floor and prevent some of the anatomical changes
that lead to stress UI and pelvic organ prolapse
(101). Similarly, learning how to respond to urgency
by staying still and using urge suppression strategies,
rather than rushing to the bathroom, may enable
people to control their voiding patterns, rather than
lose control of urgency and voiding frequency.
Conclusions
This review has focused on behavioural and lifestyle
factors that affect bladder health, explored associated
risk for bladder conditions, and discussed modifica-
tions of these factors that contribute to maintenance
or improvement of bladder health. Many of the
behavioural modifications discussed can be employed
to improve bladder health or to prevent or reduce the
deterioration of bladder health. There are several key
behavioural and lifestyle modifications that may be
beneficial to incorporate into new or existing interven-
tions to further improve the health of a population.
• ‘Understand your bladder.’ The more general
knowledge you acquire and assimilate into your life-
style, the more likely you are to prevent bladder
health problems.
• Do not smoke.
• Consume a healthy amount of fluid (25–30 ml/kg/
day, the amount needed to empty the bladder every
3–4 h).
• Eliminate or consume known bladder irritants in
moderation.
• Adopt healthy toileting behaviours.
• Practice pelvic floor muscle exercises and preemp-
tive pelvic floor contraction.
• Practice postcoital hygiene (women).
• Avoid constipation and obesity.
Although clinical practice may be assumed to be
the most appropriate ground for this education, there
is a need to disseminate the ‘bladder basics’ more
broadly and educate at-risk populations, as well as
the general public. It is crucial to extend these mes-
sages into the general population using broader pub-
lic health interventions to reach those who have not
yet developed bladder conditions and to maximise
the prevention impact of these behaviour changes.
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